Marketplace

Filters:

  • (Press "esc" to clear)

Medicine

St. Elizabeth Hospital Achieves Meaningful Use Stage 2 Criteria with Engage

/PRNewswire/ -- Defying the national trend of only 1.5 percent of eligible hospitals attesting in 2014, St. Elizabeth Hospital in Enumclaw, Wash. achieved Meaningful Use Stage 2 using MEDITECH technology. St. Elizabeth accomplished Stage 2 with information technology (IT) support from Engage, a division of Inland Northwest Health Services (INHS).

View | Comment

Medicine

Channels:

MEDIA ALERT Meridian Health to Host The Baton Pass™ with Special Guests Struck Boyz Dance Troupe; Neptune Mayor Dr. Michael Brantley to declare “Baton Pass Day” in Neptune, NJ

Siemens and Stand Up To Cancer® spread message of hope, highlight promise of research through national campaign Join the campaign at facebook.com/TheBatonPass

View | Comment

Medicine

Keywords:

Academy of Nutrition and Dietetics Debuts New Online Platform to Support Patient Care, Data Collection, Outcomes Research

The Academy of Nutrition and Dietetics has created a unique web application platform with tools to help registered dietitian nutritionists provide the highest-quality care for patients and clients, track outcomes of their interventions, conduct research in important areas of nutrition science and contribute to a national quality registry.

View | Comment

Medicine

Channels:

Keywords:

University of Tennessee-Developed Disease Detection Technology En Route to Marketplace

Meridian Bioscience Inc. has entered into a technology and commercial license agreement with the UT Research Foundation for the development of the technology that could result in low cost, point-of-care disease detection using a portable device. Meridian Bioscience is a life science company that manufactures, markets and distributes a range of diagnostic test kits and other technologies.

View | Comment

Medicine

Keywords:

23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn’s Disease

23andMe and Pfizer Inc. announce a new research collaboration to study Inflammatory Bowel Disease (IBD) in a nationwide initiative designed to recruit and genotype individuals who have Crohn’s disease or ulcerative colitis.

View | Comment

Medicine

First MEDITECH Critical Access Hospital in the Nation Achieves Stage 2 Meaningful Use Attestation with Engage

Odessa Memorial Healthcare Center in Odessa, Wash. is the first Critical Access Hospital (CAH) to successfully attest to Stage 2 of the Meaningful Use electronic health record (EHR) incentive program using MEDITECH Information Technology, Inc. administered by Engage, a division of Inland Northwest Health Services (INHS).

View | Comment

Medicine

Keywords:

TAXIS Pharmaceuticals Expands Research Portfolio

TAXIS Pharmaceuticals, Inc. today announced the acquisition of a group of novel antimicrobial drug candidates from Biota Pharmaceuticals Inc.

View | Comment

Business

Diener Precision Pumps exhibits at AACC 2014 Annual Meeting & Clinical Lab Expo

From 29 – 31 July 2014, the Swiss quality pump and valve manufacturer Diener Precision Pumps presents its precision pumps at the AACC 2014 Annual Meeting & Clinical Lab Expo in Chicago, Illinois (USA). The AACC Annual Meeting & Clinical Lab Expo is the world’s largest gathering for laboratory medicine. Double Ended – Dual Dispensing Piston Pumps and the Silencer Gear Pump Series will be the main focus of Diener Precision Pumps’ AACC appearance.

View | Comment

Business

Diener Precision Pumps Intensifies Market Presence in the USA

The Swiss quality manufacturer of precision pumps and valves Diener Precision Pumps increases its market presence in the USA. With its first-time participation as exhibitor at the AACC Annual Meeting & Clinical Lab Expo from 29 – 31 July 2014 in Chicago, Illinois, the company addresses specifically the US-American audience. Double Ended – Dual Dispensing Piston Pumps and the Silencer Gear Pump Series will be the focal point of Diener Precision Pumps’ AACC appearance.

View | Comment

Medicine

SAGE® Labs Licenses CRISPR/Cas9 Technology from the Broad Institute

SAGE Labs Inc., a leading provider of products, services and technologies in the field of genome engineering, announced today that they have licensed CRISPR/Cas9 technology from the Broad Institute. The license enables SAGE Labs to use the CRISPR/Cas9 system to engineer cell and animal models for their clients as well as distribute validated CRISPR reagents. This is the second license obtained by SAGE Labs around CRISPR/Cas9 technology; SAGE also obtained a license from Caribou Biosciences in September 2013.

View | Comment